TKNO

What one share of Alpha Teknova holds

In Vitro and In Vivo Diagnostic Substances

Alpha Teknova, Inc. (referred to herein as the Company, Teknova, we, us or our) is a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics.

Alpha Teknova’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.82
Profit−$0.31
Capex (buildings and equipment)$0.02
Free cash flow−$0.14
Cash and investments$0.11
Debt$0.25
Book value$1.17

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2020$8.23$0.16$1.44−$0.78—$4.66
2021$2.29−$0.61$1.24−$1.80—$5.11
2022$1.47−$1.69$1.00−$1.98—$3.54
2023$1.15−$1.16$0.25−$0.84—$2.21
2024$0.81−$0.57$0.02−$0.29—$1.54
2025$0.76−$0.32$0.02−$0.18—$1.28

Common questions about Alpha Teknova

How much does one share of Alpha Teknova earn?

Over the last 12 months, Alpha Teknova lost $0.31 for each share on $0.82 of sales.

Does Alpha Teknova pay a dividend?

Alpha Teknova didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Alpha Teknova’s book value per share?

Alpha Teknova’s book value is $1.17 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Alpha Teknova have?

Each share of Alpha Teknova has $0.11 of cash and investments and $0.25 of debt, as of June 30, 2026.

What is Alpha Teknova’s free cash flow per share?

−$0.14 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Alpha Teknova bought back shares?

Alpha Teknova’s share count rose about 1307% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.